XML 66 R49.htm IDEA: XBRL DOCUMENT v3.24.0.1
Business Combination - Schedule of Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Thousands
 6 Months Ended 7 Months Ended 12 Months Ended
May 24, 2022
Jun. 30, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Business Acquisition [Line Items]            
Total purchase consideration, net of $46,548 cash acquired       $ 0 $ 999,120 $ 0
Liabilities            
Goodwill     $ 409,049 416,821 409,049  
Measurement period adjustment            
Accounts receivable, net   $ (200)        
Goodwill       7,772    
Antares Pharma, Inc            
Business Acquisition [Line Items]            
Cash acquired $ 46,548          
Total purchase consideration, net of $46,548 cash acquired     999,120 999,120    
Assets:            
Short-term investments     498 498 498  
Accounts receivable, net     82,160 81,960 82,160  
Inventories, net     28,068 28,068 28,068  
Prepaid expenses and other assets     5,241 5,241 5,241  
Prepaid expenses and other assets     28,661 28,661 28,661  
Intangibles, net     589,800 589,800 589,800  
Liabilities            
Accounts Payable     7,197 7,197 7,197  
Accrued expenses     41,654 43,692 41,654  
Deferred revenue, current portion     2,509 2,509 2,509  
Deferred revenue, net of current portion     1,207 1,207 1,207  
Deferred tax liabilities, net     71,002 76,536 71,002  
Other long-term liabilities     20,788 20,788 20,788  
Net assets acquired, excluding goodwill     590,071 582,299 590,071  
Goodwill     $ 409,049 $ 416,821 $ 409,049  
Measurement period adjustment            
Accounts receivable, net   (200)        
Accrued expenses   2,038        
Deferred tax liabilities, net   5,534        
Other long-term liabilities   0        
Net assets acquired, excluding goodwill   (7,772)        
Goodwill   $ 7,772